Granules India has informed that the Board of Directors of the Company at its meeting held on January 28, 2016, has declared third interim dividend of 15 paise per share of face value of Re 1 each representing 15% of paid-up capital for the financial year 2015-16, and approved further investment of USD 1.8 mn by way of debt/equity in Granules Pharmaceutical Inc., a wholly owned foreign subsidiary of the Company.
The above information is a part of company’s filings submitted to BSE.